Ambani Orgochem（AMBANIORGO）株式概要アンバニ・オルゴケム・リミテッドはインドで水系特殊化学品の製造、加工、輸入、供給を行っている。 詳細AMBANIORGO ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績1/6財務の健全性3/6配当金0/6リスク分析株式の流動性は非常に低い 利払いは収益で十分にカバーされない 過去5年間で収益は年間25.3%減少しました。 過去1年間で株主の希薄化が進んだ +2 さらなるリスクすべてのリスクチェックを見るAMBANIORGO Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹140.4012.0% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture05b2016201920222025202620282031Revenue ₹4.8bEarnings ₹8.2mAdvancedSet Fair ValueView all narrativesAmbani Orgochem Limited 競合他社Resonance SpecialtiesSymbol: BSE:524218Market cap: ₹1.5bRenol PolychemSymbol: NSEI:RNPLMarket cap: ₹782.5mDeepak ChemtexSymbol: BSE:544036Market cap: ₹959.8mEiko LifeSciencesSymbol: BSE:540204Market cap: ₹751.5m価格と性能株価の高値、安値、推移の概要Ambani Orgochem過去の株価現在の株価₹140.4052週高値₹143.6552週安値₹94.90ベータ-0.0981ヶ月の変化6.36%3ヶ月変化6.85%1年変化27.12%3年間の変化8.80%5年間の変化73.44%IPOからの変化110.65%最新ニュースお知らせ • May 19Ambani Orgochem Limited to Report Second Half, 2026 Results on May 21, 2026Ambani Orgochem Limited announced that they will report second half, 2026 results on May 21, 2026分析記事 • Feb 14Ambani Orgochem Limited (NSE:AMBANIORGO) Soars 31% But It's A Story Of Risk Vs RewardThose holding Ambani Orgochem Limited ( NSE:AMBANIORGO ) shares would be relieved that the share price has rebounded...分析記事 • Nov 21Potential Upside For Ambani Orgochem Limited (NSE:AMBANIORGO) Not Without RiskWhen close to half the companies operating in the Chemicals industry in India have price-to-sales ratios (or "P/S...New Risk • Nov 20New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹872.3m (US$9.83m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Shares are highly illiquid. Earnings have declined by 25% per year over the past 5 years. Market cap is less than US$10m (₹872.3m market cap, or US$9.83m). Minor Risks Profit margins are more than 30% lower than last year (0.2% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding).お知らせ • Nov 14Ambani Orgochem Limited to Report First Half, 2026 Results on Nov 14, 2025Ambani Orgochem Limited announced that they will report first half, 2026 results on Nov 14, 2025Board Change • Sep 10Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.最新情報をもっと見るRecent updatesお知らせ • May 19Ambani Orgochem Limited to Report Second Half, 2026 Results on May 21, 2026Ambani Orgochem Limited announced that they will report second half, 2026 results on May 21, 2026分析記事 • Feb 14Ambani Orgochem Limited (NSE:AMBANIORGO) Soars 31% But It's A Story Of Risk Vs RewardThose holding Ambani Orgochem Limited ( NSE:AMBANIORGO ) shares would be relieved that the share price has rebounded...分析記事 • Nov 21Potential Upside For Ambani Orgochem Limited (NSE:AMBANIORGO) Not Without RiskWhen close to half the companies operating in the Chemicals industry in India have price-to-sales ratios (or "P/S...New Risk • Nov 20New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹872.3m (US$9.83m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Shares are highly illiquid. Earnings have declined by 25% per year over the past 5 years. Market cap is less than US$10m (₹872.3m market cap, or US$9.83m). Minor Risks Profit margins are more than 30% lower than last year (0.2% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding).お知らせ • Nov 14Ambani Orgochem Limited to Report First Half, 2026 Results on Nov 14, 2025Ambani Orgochem Limited announced that they will report first half, 2026 results on Nov 14, 2025Board Change • Sep 10Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Sep 04Ambani Orgochem Limited, Annual General Meeting, Sep 27, 2025Ambani Orgochem Limited, Annual General Meeting, Sep 27, 2025, at 12:00 Indian Standard Time.Board Change • Aug 18Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.New Risk • Jul 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Shares are highly illiquid. Earnings have declined by 14% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (₹991.8m market cap, or US$11.6m).分析記事 • Jul 05Ambani Orgochem (NSE:AMBANIORGO) May Have Issues Allocating Its CapitalIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Board Change • Jul 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • May 15Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Feb 17Ambani Orgochem Limited Resumes Commercial Productions of Manufacturing Plant Located At Dahej Industrial Area, Dist - BharuchAmbani Orgochem Limited has resumed commercial productions of manufacturing plant located at D-3 167, 168 & D-3 169, Dahej Industrial Area, Dist Bharuch Gujarat 392 165 with effect from February 15, 2025.分析記事 • Dec 23Ambani Orgochem Limited's (NSE:AMBANIORGO) 37% Share Price Surge Not Quite Adding UpAmbani Orgochem Limited ( NSE:AMBANIORGO ) shares have continued their recent momentum with a 37% gain in the last...Valuation Update With 7 Day Price Move • Dec 13Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹136, the stock trades at a trailing P/E ratio of 76.3x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 46% over the past three years.Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹105, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 4.5% over the past three years.分析記事 • Nov 08Ambani Orgochem Limited (NSE:AMBANIORGO) Held Back By Insufficient Growth Even After Shares Climb 25%Ambani Orgochem Limited ( NSE:AMBANIORGO ) shareholders are no doubt pleased to see that the share price has bounced...New Risk • Nov 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.3x net interest cover). High level of non-cash earnings (33% accrual ratio). Market cap is less than US$10m (₹609.8m market cap, or US$7.24m). Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change).Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹92.65, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total loss to shareholders of 13% over the past three years.お知らせ • Sep 16Ambani Orgochem Limited, Annual General Meeting, Sep 30, 2024Ambani Orgochem Limited, Annual General Meeting, Sep 30, 2024, at 16:00 Indian Standard Time.分析記事 • Aug 28Investors Don't See Light At End Of Ambani Orgochem Limited's (NSE:AMBANIORGO) TunnelAmbani Orgochem Limited's ( NSE:AMBANIORGO ) price-to-earnings (or "P/E") ratio of 22.6x might make it look like a buy...Board Change • Jul 25Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Jul 23Ambani Organics Limited Announces Resignation of Dilipkumar Vikamchand Mehta as Non-Executive DirectorAmbani Organics Limited announced resignation of Dilipkumar Vikamchand Mehta as Non-Executive Director, effective July 23, 2024.New Risk • May 28New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Shares are highly illiquid. Earnings have declined by 4.4% per year over the past 5 years. High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (0.4% net profit margin). Market cap is less than US$100m (₹844.3m market cap, or US$10.2m).お知らせ • Feb 22Ambani Organics Limited Announces Directorate AppointmentsDirectors of Ambani Organics Limited at its meeting held on Tuesday, February 20, 2024 has approved the following. Mr. Bhavin Jitendra Patel, Date of Birth 14 March 1996. Age is 27 years. Mr. Bhavin Jitendra Patel is appointed as the Additional Director (Non-Executive Director) of the Company with effect from February 20, 2024 liable to retire by rotation. Mr. Bhavin Jitendra Patel has Experience of four years with Ambani Organic Limited. He has qualification of B.E. Petrochemical Engineering. Currently, he is designated as Genearal Manager at Dahej Plant of Ambani Organic Limited. Mr. Neerajkumar Amarjeet Pandey, Date of Birth 02 January 1972 Age 52 years, Mr. Neerajkumar Amarjeet Pandey is appointed as the Additional Director (Non- Executive Director) of the Company with effect from February 20, 2024 liable to retire by rotation. Mr. Neerajkumar Amarjeet Pandey has over Three Decades of experience out of which 22 years with Ambani Organic Limited. He has qualification of BSc (Chemical). Currently, he is designted as Genearal Manager at Tarapur Plant of Ambani Organic Limited.New Risk • Nov 18New major risk - Revenue and earnings growthEarnings have declined by 4.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Earnings have declined by 4.4% per year over the past 5 years. High level of non-cash earnings (22% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Profit margins are more than 30% lower than last year (0.4% net profit margin). Market cap is less than US$100m (₹890.9m market cap, or US$10.7m).Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹119, the stock trades at a trailing P/E ratio of 59.2x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 181% over the past three years.New Risk • Sep 16New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.0% Last year net profit margin: 1.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.2x net interest cover). High level of non-cash earnings (27% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (1.0% net profit margin). Market cap is less than US$100m (₹932.7m market cap, or US$11.2m).お知らせ • Sep 09Ambani Organics Limited, Annual General Meeting, Sep 29, 2023Ambani Organics Limited, Annual General Meeting, Sep 29, 2023, at 17:00 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023, together with the Reports of the Board of Directors and the Auditors thereon; to consider and appoint a Director in place of Mr. Sharad P Kothari , who retires by rotation at this Annual General Meeting and being eligible has offered himself for re- appointment; to consider and ratify the remuneration payable to the Cost Auditor appointed by the Board of Directors of the Company for the financial year 2022-2023.分析記事 • Aug 25Is Ambani Organics (NSE:AMBANIORG) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹141, the stock trades at a trailing P/E ratio of 45.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 147% over the past three years.New Risk • Jul 01New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹816.6m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Share price has been highly volatile over the past 3 months (9.9% average weekly change). High level of non-cash earnings (27% accrual ratio). Market cap is less than US$10m (₹816.6m market cap, or US$9.95m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding).Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹149, the stock trades at a trailing P/E ratio of 48.6x. Average trailing P/E is 21x in the Chemicals industry in India.Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹1.07 (vs ₹3.06 in FY 2022)Full year 2023 results: EPS: ₹1.07. Revenue: ₹1.33b (up 6.5% from FY 2022). Net income: ₹19.8m (up 15% from FY 2022). Profit margin: 1.5% (up from 1.4% in FY 2022). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Apr 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹103, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 93% over the past three years.Board Change • Apr 10Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Feb 07Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Nov 23Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Oct 22Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Sep 05Ambani Organics Limited, Annual General Meeting, Sep 26, 2022Ambani Organics Limited, Annual General Meeting, Sep 26, 2022, at 15:00 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the Reports of the Board of Directors and the Auditors thereon; to receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2022, together with the Report of the Auditors thereon; to appoint a Director in place of Mr. Dilipkumar Vikramchand, who retires by rotation at this Annual General Meeting and being eligible has offered himself for re-appointment; and to re-appoint M/s. Shambhu Gupta & Co, Chartered Accountants as the statutory auditors of the company and to fix their remuneration.Board Change • Aug 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Jun 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • May 11Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 22Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 07Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Feb 15Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Sep 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹68.60, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 3.8% over the past three years.分析記事 • Sep 01We Think Ambani Organics (NSE:AMBANIORG) Is Taking Some Risk With Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • Jun 30Full year 2021 earnings released: EPS ₹3.35 (vs ₹2.72 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹873.6m (up 19% from FY 2020). Net income: ₹17.0m (up 23% from FY 2020). Profit margin: 1.9% (in line with FY 2020).Valuation Update With 7 Day Price Move • Jun 18Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹72.85, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 22x in the Chemicals industry in India.Valuation Update With 7 Day Price Move • May 29Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to ₹80.95, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 20x in the Chemicals industry in India.Valuation Update With 7 Day Price Move • May 06Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹60.00, the stock trades at a trailing P/E ratio of 26.6x. Average trailing P/E is 19x in the Chemicals industry in India.分析記事 • Jan 28These 4 Measures Indicate That Ambani Organics (NSE:AMBANIORG) Is Using Debt ExtensivelyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...お知らせ • Jul 17Ambani Organics Limited to Report Fiscal Year 2020 Results on Jul 17, 2020Ambani Organics Limited announced that they will report fiscal year 2020 results on Jul 17, 2020株主還元AMBANIORGOIN ChemicalsIN 市場7D0%0.3%0.5%1Y27.1%-2.9%-0.5%株主還元を見る業界別リターン: AMBANIORGO過去 1 年間で-2.9 % の収益を上げたIndian Chemicals業界を上回りました。リターン対市場: AMBANIORGO過去 1 年間で-0.5 % の収益を上げたIndian市場を上回りました。価格変動Is AMBANIORGO's price volatile compared to industry and market?AMBANIORGO volatilityAMBANIORGO Average Weekly Movementn/aChemicals Industry Average Movement7.3%Market Average Movement7.1%10% most volatile stocks in IN Market10.1%10% least volatile stocks in IN Market4.8%安定した株価: AMBANIORGOの株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のAMBANIORGOのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト1985n/aParesh Shahambaniorganics.comAmbani Orgochem 社はインドで水系特殊化学品の製造、加工、輸入、供給を行っている。同社の製品には、ターシャリーブチルヒドロペルオキシド、ジターシャリーブチルペルオキシド、ターシャリーブチルペルオキシド、ジベンゾイルペルオキシド、メチルエチルケトンペルオキシドなどの有機過酸化物、促進剤、アクリルエマルジョン、銀イオン殺菌剤などがある。コバルト、マンガン、鉛、カルシウム、亜鉛、ジルコニウム、カリウム、バリウム、カドミウム、セリウム、ストロンチウム、鉄、銅、ナフテン酸コバルトオクテートなどのペイントドライヤー、コンビネーションドライヤー、水分散性ドライヤー、サリチル酸、サリチル酸メチル、サリチル酸オクチル、TBHPなどを提供している。同社の製品は、塗料、複合材料/FRP、繊維、紙、接着剤、カーペット、建築、木材、医薬品など様々な産業用途で使用されている。同社は製品を輸出している。旧社名は Ambani Organics Limited で、2024 年 6 月に Ambani Orgochem Limited に社名変更。アンバニ・オルゴケムは1985年に設立され、インドのムンバイに拠点を置く。もっと見るAmbani Orgochem Limited 基礎のまとめAmbani Orgochem の収益と売上を時価総額と比較するとどうか。AMBANIORGO 基礎統計学時価総額₹1.08b収益（TTM）₹3.72m売上高(TTM)₹2.20b289.1xPER（株価収益率0.5xP/SレシオAMBANIORGO は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計AMBANIORGO 損益計算書（TTM）収益₹2.20b売上原価₹1.62b売上総利益₹580.75mその他の費用₹577.03m収益₹3.72m直近の収益報告Sep 30, 2025次回決算日該当なし一株当たり利益（EPS）0.49グロス・マージン26.41%純利益率0.17%有利子負債／自己資本比率106.3%AMBANIORGO の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 08:34終値2026/05/08 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ambani Orgochem Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 19Ambani Orgochem Limited to Report Second Half, 2026 Results on May 21, 2026Ambani Orgochem Limited announced that they will report second half, 2026 results on May 21, 2026
分析記事 • Feb 14Ambani Orgochem Limited (NSE:AMBANIORGO) Soars 31% But It's A Story Of Risk Vs RewardThose holding Ambani Orgochem Limited ( NSE:AMBANIORGO ) shares would be relieved that the share price has rebounded...
分析記事 • Nov 21Potential Upside For Ambani Orgochem Limited (NSE:AMBANIORGO) Not Without RiskWhen close to half the companies operating in the Chemicals industry in India have price-to-sales ratios (or "P/S...
New Risk • Nov 20New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹872.3m (US$9.83m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Shares are highly illiquid. Earnings have declined by 25% per year over the past 5 years. Market cap is less than US$10m (₹872.3m market cap, or US$9.83m). Minor Risks Profit margins are more than 30% lower than last year (0.2% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding).
お知らせ • Nov 14Ambani Orgochem Limited to Report First Half, 2026 Results on Nov 14, 2025Ambani Orgochem Limited announced that they will report first half, 2026 results on Nov 14, 2025
Board Change • Sep 10Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 19Ambani Orgochem Limited to Report Second Half, 2026 Results on May 21, 2026Ambani Orgochem Limited announced that they will report second half, 2026 results on May 21, 2026
分析記事 • Feb 14Ambani Orgochem Limited (NSE:AMBANIORGO) Soars 31% But It's A Story Of Risk Vs RewardThose holding Ambani Orgochem Limited ( NSE:AMBANIORGO ) shares would be relieved that the share price has rebounded...
分析記事 • Nov 21Potential Upside For Ambani Orgochem Limited (NSE:AMBANIORGO) Not Without RiskWhen close to half the companies operating in the Chemicals industry in India have price-to-sales ratios (or "P/S...
New Risk • Nov 20New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹872.3m (US$9.83m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Shares are highly illiquid. Earnings have declined by 25% per year over the past 5 years. Market cap is less than US$10m (₹872.3m market cap, or US$9.83m). Minor Risks Profit margins are more than 30% lower than last year (0.2% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding).
お知らせ • Nov 14Ambani Orgochem Limited to Report First Half, 2026 Results on Nov 14, 2025Ambani Orgochem Limited announced that they will report first half, 2026 results on Nov 14, 2025
Board Change • Sep 10Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 04Ambani Orgochem Limited, Annual General Meeting, Sep 27, 2025Ambani Orgochem Limited, Annual General Meeting, Sep 27, 2025, at 12:00 Indian Standard Time.
Board Change • Aug 18Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
New Risk • Jul 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Shares are highly illiquid. Earnings have declined by 14% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (₹991.8m market cap, or US$11.6m).
分析記事 • Jul 05Ambani Orgochem (NSE:AMBANIORGO) May Have Issues Allocating Its CapitalIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...
Board Change • Jul 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • May 15Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Feb 17Ambani Orgochem Limited Resumes Commercial Productions of Manufacturing Plant Located At Dahej Industrial Area, Dist - BharuchAmbani Orgochem Limited has resumed commercial productions of manufacturing plant located at D-3 167, 168 & D-3 169, Dahej Industrial Area, Dist Bharuch Gujarat 392 165 with effect from February 15, 2025.
分析記事 • Dec 23Ambani Orgochem Limited's (NSE:AMBANIORGO) 37% Share Price Surge Not Quite Adding UpAmbani Orgochem Limited ( NSE:AMBANIORGO ) shares have continued their recent momentum with a 37% gain in the last...
Valuation Update With 7 Day Price Move • Dec 13Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹136, the stock trades at a trailing P/E ratio of 76.3x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 46% over the past three years.
Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹105, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 4.5% over the past three years.
分析記事 • Nov 08Ambani Orgochem Limited (NSE:AMBANIORGO) Held Back By Insufficient Growth Even After Shares Climb 25%Ambani Orgochem Limited ( NSE:AMBANIORGO ) shareholders are no doubt pleased to see that the share price has bounced...
New Risk • Nov 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.3x net interest cover). High level of non-cash earnings (33% accrual ratio). Market cap is less than US$10m (₹609.8m market cap, or US$7.24m). Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change).
Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹92.65, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total loss to shareholders of 13% over the past three years.
お知らせ • Sep 16Ambani Orgochem Limited, Annual General Meeting, Sep 30, 2024Ambani Orgochem Limited, Annual General Meeting, Sep 30, 2024, at 16:00 Indian Standard Time.
分析記事 • Aug 28Investors Don't See Light At End Of Ambani Orgochem Limited's (NSE:AMBANIORGO) TunnelAmbani Orgochem Limited's ( NSE:AMBANIORGO ) price-to-earnings (or "P/E") ratio of 22.6x might make it look like a buy...
Board Change • Jul 25Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Jul 23Ambani Organics Limited Announces Resignation of Dilipkumar Vikamchand Mehta as Non-Executive DirectorAmbani Organics Limited announced resignation of Dilipkumar Vikamchand Mehta as Non-Executive Director, effective July 23, 2024.
New Risk • May 28New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Shares are highly illiquid. Earnings have declined by 4.4% per year over the past 5 years. High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (0.4% net profit margin). Market cap is less than US$100m (₹844.3m market cap, or US$10.2m).
お知らせ • Feb 22Ambani Organics Limited Announces Directorate AppointmentsDirectors of Ambani Organics Limited at its meeting held on Tuesday, February 20, 2024 has approved the following. Mr. Bhavin Jitendra Patel, Date of Birth 14 March 1996. Age is 27 years. Mr. Bhavin Jitendra Patel is appointed as the Additional Director (Non-Executive Director) of the Company with effect from February 20, 2024 liable to retire by rotation. Mr. Bhavin Jitendra Patel has Experience of four years with Ambani Organic Limited. He has qualification of B.E. Petrochemical Engineering. Currently, he is designated as Genearal Manager at Dahej Plant of Ambani Organic Limited. Mr. Neerajkumar Amarjeet Pandey, Date of Birth 02 January 1972 Age 52 years, Mr. Neerajkumar Amarjeet Pandey is appointed as the Additional Director (Non- Executive Director) of the Company with effect from February 20, 2024 liable to retire by rotation. Mr. Neerajkumar Amarjeet Pandey has over Three Decades of experience out of which 22 years with Ambani Organic Limited. He has qualification of BSc (Chemical). Currently, he is designted as Genearal Manager at Tarapur Plant of Ambani Organic Limited.
New Risk • Nov 18New major risk - Revenue and earnings growthEarnings have declined by 4.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Earnings have declined by 4.4% per year over the past 5 years. High level of non-cash earnings (22% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Profit margins are more than 30% lower than last year (0.4% net profit margin). Market cap is less than US$100m (₹890.9m market cap, or US$10.7m).
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹119, the stock trades at a trailing P/E ratio of 59.2x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 181% over the past three years.
New Risk • Sep 16New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.0% Last year net profit margin: 1.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.2x net interest cover). High level of non-cash earnings (27% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (1.0% net profit margin). Market cap is less than US$100m (₹932.7m market cap, or US$11.2m).
お知らせ • Sep 09Ambani Organics Limited, Annual General Meeting, Sep 29, 2023Ambani Organics Limited, Annual General Meeting, Sep 29, 2023, at 17:00 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023, together with the Reports of the Board of Directors and the Auditors thereon; to consider and appoint a Director in place of Mr. Sharad P Kothari , who retires by rotation at this Annual General Meeting and being eligible has offered himself for re- appointment; to consider and ratify the remuneration payable to the Cost Auditor appointed by the Board of Directors of the Company for the financial year 2022-2023.
分析記事 • Aug 25Is Ambani Organics (NSE:AMBANIORG) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹141, the stock trades at a trailing P/E ratio of 45.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 147% over the past three years.
New Risk • Jul 01New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹816.6m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Share price has been highly volatile over the past 3 months (9.9% average weekly change). High level of non-cash earnings (27% accrual ratio). Market cap is less than US$10m (₹816.6m market cap, or US$9.95m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding).
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹149, the stock trades at a trailing P/E ratio of 48.6x. Average trailing P/E is 21x in the Chemicals industry in India.
Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹1.07 (vs ₹3.06 in FY 2022)Full year 2023 results: EPS: ₹1.07. Revenue: ₹1.33b (up 6.5% from FY 2022). Net income: ₹19.8m (up 15% from FY 2022). Profit margin: 1.5% (up from 1.4% in FY 2022). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Apr 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹103, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 93% over the past three years.
Board Change • Apr 10Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Feb 07Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Nov 23Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Oct 22Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 05Ambani Organics Limited, Annual General Meeting, Sep 26, 2022Ambani Organics Limited, Annual General Meeting, Sep 26, 2022, at 15:00 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the Reports of the Board of Directors and the Auditors thereon; to receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2022, together with the Report of the Auditors thereon; to appoint a Director in place of Mr. Dilipkumar Vikramchand, who retires by rotation at this Annual General Meeting and being eligible has offered himself for re-appointment; and to re-appoint M/s. Shambhu Gupta & Co, Chartered Accountants as the statutory auditors of the company and to fix their remuneration.
Board Change • Aug 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Jun 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • May 11Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 22Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 07Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Feb 15Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Sep 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹68.60, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 3.8% over the past three years.
分析記事 • Sep 01We Think Ambani Organics (NSE:AMBANIORG) Is Taking Some Risk With Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • Jun 30Full year 2021 earnings released: EPS ₹3.35 (vs ₹2.72 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹873.6m (up 19% from FY 2020). Net income: ₹17.0m (up 23% from FY 2020). Profit margin: 1.9% (in line with FY 2020).
Valuation Update With 7 Day Price Move • Jun 18Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹72.85, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 22x in the Chemicals industry in India.
Valuation Update With 7 Day Price Move • May 29Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to ₹80.95, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 20x in the Chemicals industry in India.
Valuation Update With 7 Day Price Move • May 06Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹60.00, the stock trades at a trailing P/E ratio of 26.6x. Average trailing P/E is 19x in the Chemicals industry in India.
分析記事 • Jan 28These 4 Measures Indicate That Ambani Organics (NSE:AMBANIORG) Is Using Debt ExtensivelyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
お知らせ • Jul 17Ambani Organics Limited to Report Fiscal Year 2020 Results on Jul 17, 2020Ambani Organics Limited announced that they will report fiscal year 2020 results on Jul 17, 2020
